Blurry Boundaries: Do Epithelial Borderline Lesions of the Breast and Ductal Carcinoma In Situ Have Similar Rates of Subsequent Invasive Cancer?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The histology of epithelial “borderline lesions” of the breast, which have features in between atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS), is well described, but the clinical behavior is not. This study reports subsequent ipsilateral breast events (IBE) in patients with borderline lesions compared with those with DCIS.
Patients undergoing breast-conserving surgery for borderline lesions or DCIS from 1997 to 2010 were identified from a prospective database. IBE was defined as the diagnosis of subsequent ipsilateral DCIS or invasive ductal carcinoma.
A total of 143 borderline-lesion patients and 2,328 DCIS patients were identified. Median follow-up was 2.9 and 4.4 years, respectively. 7 borderline-lesion and 172 DCIS patients experienced an IBE. 5 year IBE rates were 7.7 % for borderline lesions and 7.2 % for DCIS (p = .80). 5 year invasive IBE rates were 6.5 and 2.8 %, respectively (p = .25). Similarly, when analyses were restricted to patients who did not receive radiotherapy, or endocrine therapy, or both, borderline-lesion and DCIS patients did not demonstrate statistically significant differences in rates of IBE or invasive IBE.
When compared with DCIS, borderline lesions do not demonstrate lower rates of IBE or invasive IBE. Despite “borderline” histology, a 5 year IBE rate of 7.7 % and an invasive IBE rate of 6.5 % suggest that the risk of future carcinoma is significant and similar to that of DCIS.
- Page, DL, Dupont, WD, Rogers, LW, Rados, MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 55: pp. 2698-2708
- Page, DL (1986) Cancer risk assessment in benign breast biopsies. Hum Pathol. 17: pp. 871-874 CrossRef
- Page, DL, Dupont, WD, Rogers, LW (1988) Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk. Hum Pathol. 19: pp. 201-207 CrossRef
- Rosai, J (1991) Borderline epithelial lesions of the breast. Am J Surg Pathol. 15: pp. 209-221 CrossRef
- Page, DL, Rogers, LW (1992) Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol. 23: pp. 1095-1097 CrossRef
- Masood, S, Rosa, M (2011) Borderline breast lesions: diagnostic challenges and clinical implications. Adv Anat Pathol. 18: pp. 190-198 CrossRef
- Rosen, PP (1991) “Borderline” breast lesions. Am J Surg Pathol. 15: pp. 1100-1102 CrossRef
- Dupont, WD, Page, DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 312: pp. 146-151 CrossRef
- Dupont, WD, Parl, FF, Hartmann, WH, Brinton, LA, Winfield, AC, Worrell, JA (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 71: pp. 1258-1265 CrossRef
- Page, DL, Dupont, WD (1990) Anatomic markers of human premalignancy and risk of breast cancer. Cancer. 66: pp. 1326-1335 CrossRef
- Hartmann, LC, Sellers, TA, Frost, MH, Lingle, WL, Degnim, AC, Ghosh, K (2005) Benign breast disease and the risk of breast cancer. N Engl J Med. 353: pp. 229-237 CrossRef
- Marshall, LM, Hunter, DJ, Connolly, JL, Schnitt, SJ, Byrne, C, London, SJ (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 6: pp. 297-301
- Fisher, B, Costantino, JP, Wickerham, DL, Cecchini, RS, Cronin, WM, Robidoux, A (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 97: pp. 1652-1662 CrossRef
- Schnitt SJ, Collins LC. Pathology of benign breast disorders. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. Philadelphia, PA: Lippincott Williams & Wilkins; 2010:71.
- Schnitt, SJ, Connolly, JL, Tavassoli, FA, Fechner, RE, Kempson, RL, Gelman, R (1992) Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol. 16: pp. 1133-1143 CrossRef
- Allred, DC, Anderson, SJ, Paik, S, Wickerham, DL, Nagtegaal, ID, Swain, SM (2012) Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 30: pp. 1268-1273 CrossRef
- Hwang, ES, Samli, B, Tran, KN, Rosen, PP, Borgen, PI, Zee, KJ (1998) Volume of resection in patients treated with breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 5: pp. 757-763 CrossRef
- Zee, KJ, Liberman, L, Samli, B, Tran, KN, McCormick, B, Petrek, JA (1999) Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer. 86: pp. 1757-1767 CrossRef
- Bijker, N, Meijnen, P, Peterse, JL, Bogaerts, J, Hoorebeeck, I, Julien, JP (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 24: pp. 3381-3387 CrossRef
- Hughes, LL, Wang, M, Page, DL, Gray, R, Solin, LJ, Davidson, NE (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 27: pp. 5319-5324 CrossRef
- Rudloff, U, Jacks, LM, Goldberg, JI, Wynveen, CA, Brogi, E, Patil, S (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 28: pp. 3762-3769 CrossRef
- Ho, A, Goenka, A, Ishill, N, Zee, K, McLane, A, Gonzales, AM (2011) The effect of age in the outcome and treatment of older women with ductal carcinoma in situ. Breast. 20: pp. 71-77 CrossRef
- Wapnir, IL, Dignam, JJ, Fisher, B, Mamounas, EP, Anderson, SJ, Julian, TB (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 103: pp. 478-488 CrossRef
- Blurry Boundaries: Do Epithelial Borderline Lesions of the Breast and Ductal Carcinoma In Situ Have Similar Rates of Subsequent Invasive Cancer?
Annals of Surgical Oncology
Volume 20, Issue 4 , pp 1302-1310
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 2. Biostatistics Service, Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA